Topic
Private Credit Research
Within the private credit landscape, researchers emphasize the continued importance of private markets and direct lending as essential tools for diversifying portfolios amidst heightened geopolitical uncertainty and credit stress. While direct lending remains supported, analysts advocate for strict selectivity with a bias toward non-cyclical sectors and infrastructure for inflation-linked income. Credit strategies demonstrated resilience with positive returns in early 2026, though a more defensive posture is emerging through the prioritization of Relative Value and Fixed Income Relative Value sub-strategies. Solid corporate fundamentals and projected S&P 500 EPS growth of 20% support the credit outlook, even as high government deficits pose long-term risks to yields and necessitate a focus on shorter-duration fixed income. Additionally, the massive expansion in AI-related demand, with a projected $1.7 trillion TAM by 2030, and the evolution of biotech into a compounding asset class are creating new long-term investment opportunities for credit providers. Collectively, these insights suggest a research direction focused on resilient, innovation-driven sectors to navigate a goldilocks environment disrupted by macro volatility.
4511 reports available
All reports
Page 181 of 188
Silver Sunrise Euro TMT Daily
J.P. Morgan · May 11, 2026
YOFC New Procurement Tender Released
Goldman Sachs · May 11, 2026
Europe First to Market
J.P. Morgan · May 11, 2026
China Cosmetics Monthly Tracker
Goldman Sachs · May 11, 2026
Emaar Properties and Emaar Development 1Q26 Earnings Update
Goldman Sachs · May 11, 2026
Chinese OEM Competition Monitor April 2026
Goldman Sachs · May 11, 2026
The Weekly Brief
J.P. Morgan · May 11, 2026
Global Healthcare: The Cardiology Renaissance
Goldman Sachs · May 11, 2026
Americas Healthcare Biotechnology 1Q26 Model Updates
Goldman Sachs · May 11, 2026
Instacart Recent Management Meetings and Q1 Earnings Themes
Goldman Sachs · May 11, 2026
Asia Pacific Bonds New Issue Focus
UBS · May 11, 2026
Fox Corp F3Q26 Earnings First Take
Goldman Sachs · May 11, 2026
Konecranes Key Takeaways From CFO Webcast
Goldman Sachs International · May 11, 2026
Mastercard Key Takeaways From Management Meetings
Goldman Sachs · May 11, 2026
House View Daily US
UBS · May 11, 2026
Midday Market Intelligence
Goldman Sachs · May 11, 2026
Systematic Flows Monitor
Bank of America · May 11, 2026
China Healthcare Services Drug Chains FY25 and 1Q26 Wrap Up
Goldman Sachs · May 11, 2026
Seronegative Approval Reinforces Vyvgart's MG Positioning
Goldman Sachs · May 11, 2026
The Point for Europe
Citi · May 11, 2026
Market Focus Shift from Buybacks to Capex
The Market Ear · May 11, 2026
Updating Estimates Post 1Q26 Amadeus IT Group
Goldman Sachs · May 11, 2026
Australian Morning Focus
ANZ · May 11, 2026
Evaluating Execution Risk for Avexitide Phase 3 Readout in Post-Bariatric Hypoglycemia
Goldman Sachs · May 11, 2026